With a background in theoretical physics, Owain has expertise in the fields of physics, electronics and telecommunications, with a particular focus on user equipment, base stations, computer software and 3GPP-related telecommunications standards including 3G, LTE, LTE-A, 4G and 5G (NR).
In addition to having drafted patent applications in these fields, he has significant experience of patent application prosecution at the European Patent Office, including having represented clients at numerous examination Oral Proceedings at the EPO. Owain has also prosecuted patent applications at the UK IPO.
Owain entered the patent profession in 2013, joining HGF at their York office. In 2016, he qualified as a European Patent Attorney and a Chartered Patent Attorney.
MPhys in Theoretical Physics
Postgraduate Certificate in Intellectual Property
Owain has mentored junior colleagues to assist in their preparation for the European Qualifying Examinations, and has also acted as a tutor to assist in preparation for the European Qualifying Examinations and UK final Qualifying Examinations for a Patent Attorney.
Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …Read article
Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder . …Read article
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.